BAI1

CAS No. 335165-68-9

BAI1( —— )

Catalog No. M20096 CAS No. 335165-68-9

BAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 72 In Stock
10MG 115 In Stock
25MG 228 In Stock
50MG 417 In Stock
100MG 614 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BAI1
  • Note
    Research use only, not for human use.
  • Brief Description
    BAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).
  • Description
    BAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).
  • In Vitro
    Apoptosis Analysis Cell Line:Mouse MEF Concentration:0.3125 μM , 0.625 μM, 1 μM, 1.25 μM, 1.5 μM, 2.5 μM , 3 μM, 4 μM, 5 4 μM, 10 4 μM Incubation Time:8 hours Result:Inhibited cell death in BAX-dependent manner.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bax
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    335165-68-9
  • Formula Weight
    467.2
  • Molecular Formula
    C19H21Br2N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 15 mg/mL (32.1 mM);Water: Insoluble
  • SMILES
    OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bombrun A et al. 36-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulation. J Med Chem. 2003 Oct 9;46(21):4365-8.
molnova catalog
related products
  • Lisaftoclax

    Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.

  • S-63845

    S-63845 (S63845)?is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM.

  • Navitoclax-piperazin...

    Navitoclax-piperazine is an inhibitor of B-cell lymphoma extra large (BCL-XL).